Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies

Clinical Reviews in Allergy and Immunology

Volumn 40, Issue 1, 2011, Pages 27-41

  Brucato, Antonio ^a   Cimaz, Rolando ^b   Caporali, Roberto ^c   Ramoni, Véronique ^a,c   Buyon, Jill ^d  

^a OSPEDALI RIUNITI   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti Ro SSA antibodies; Heart block congenital; Neonatal lupus

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETAMETHASONE; CORTICOSTEROID; DEXAMETHASONE; IMMUNOGLOBULIN; LA ANTIBODY; RITODRINE; RO ANTIBODY; SALBUTAMOL; TERBUTALINE;

APOPTOSIS; ARRHYTHMOGENESIS; ARTHRALGIA; ARTICLE; ATRIOVENTRICULAR BLOCK; AUTOIMMUNE DISEASE; CARDIOMYOPATHY; CLINICAL FEATURE; CONGENITAL HEART BLOCK; DELIVERY; ECHOCARDIOGRAPHY; ECHOGRAPHY; ELECTROPHYSIOLOGY; GENETICS; HEMATOLOGIC DISEASE; HUMAN; LIVER DISEASE; LUPUS ERYTHEMATOSUS; LUPUS ERYTHEMATOSUS NEPHRITIS; NEUROPHYSIOLOGY; NEWBORN HEMOLYTIC DISEASE; NEWBORN PERIOD; NONHUMAN; PATHOGENESIS; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE; PREVALENCE; PROGENY; PROGNOSIS; RASH; RECURRENT DISEASE; RHEUMATIC DISEASE; XEROPHTHALMIA;

ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; FEMALE; HEART BLOCK; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 79951672892     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-009-8190-6     Document Type: Article

References (113)

1. F Franceschini I Cavazzana 2005 Anti-Ro/SSA and La/SSB antibodies Autoimmunity 38 55 63 1:CAS:528:DC%2BD2MXislygtb4%3D 15804706 (Pubitemid 40515004)
2. EL Greidinger Y Zang L Martinez, et al. 2007 Differential tissue targeting of autoimmunity manifestations by autoantigen-associated Y RNAs Arthritis Rheum 56 1589 1597 1:CAS:528:DC%2BD2sXmsFartL0%3D 17469141 (Pubitemid 46764088)
3. V Codullo A Bardoni R Salvini C Montecucco 2006 Antinuclear antibodies in systemic sclerosis Future Rheumatol 1 365 371 1:CAS:528:DC%2BD28Xntlyqs74%3D
4. JG Routsias AG Tzioufas 2007 Sjögren's syndrome-study of autoantigens and autoantibodies Clin Rev Allergy Immunol 32 238 251 1:CAS:528:DC%2BD1cXitFei 17992591
5. GJ Pruijn FH Simons WJ van Venrooij 1997 Intracellular localization and nucleocytoplasmic transport of Ro RNP components Eur J Cell Biol 74 123 132 1:CAS:528:DyaK2sXmslSqsLk%3D 9352217 (Pubitemid 27455389)
6. SL Wolin KM Reinisch 2006 The Ro 60 kDa autoantigen comes into focus: interpreting epitope mapping experiments on the basis of structure Autoimmunity Rev 5 367 372 1:CAS:528:DC%2BD28XhtVGiu73K (Pubitemid 44143028)
7. KEE Elagib P Tengner M Levi, et al. 1999 Immunoglobulin variable genes and epitope recognition of human monoclonal anti-Ro 52-kd in primary Sjögren's syndrome Arthritis Rheum 42 2471 2481 1:CAS:528: DyaK1MXnvVShsbg%3D 10555043 (Pubitemid 30333428)
8. N Belfiore S Rossi F Bobbio-Pallavicini O Epis R Caporali C Montecucco 2000 Anti-Ro(SS-A) 52 kDa and 60 kDa specificities in undifferentiated connective tissue disease Jt Bone Spine 67 183 187 1:STN:280: DC%2BD3M%2FhtVCquw%3D%3D (Pubitemid 30353454)
9. JE Gottenberg M Busson P Loiseau, et al. 2003 In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response Arthritis Rheum 48 2240 2245 1:CAS:528:DC%2BD3sXntVWgsbg%3D 12905478 (Pubitemid 36959205)
10. S Salomonsson T Dorner E Theander K Bremme P Larsson M Wahren-Herlenius 2002 A serologic marker for fetal risk of congenital heart block Arthritis Rheum 46 1233 1241 1:CAS:528:DC%2BD38XksVygu7s%3D 12115229 (Pubitemid 34525831)
11. RM Clancy JP Buyon K Ikeda, et al. 2005 Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects Arthritis Rheum 52 3079 3086 1:CAS:528:DC%2BD2MXhtF2msrrK 16200587 (Pubitemid 41447089)
12. L Strandberg O Winqvist SE Sonesson, et al. 2008 Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block Clin Exp Immunol 154 30 37 1:CAS:528:DC%2BD1cXht1Cmu73J 18727629
13. RG Hull EN Harris SH Morgan GR Hughes 1983 Anti-Ro antibodies and abortions in women with SLE Lancet 2 1138 1:STN:280:DyaL2c%2FjvVGmsQ%3D%3D 6138662 (Pubitemid 14242404)
14. CS Barclay MA French LD Ross RJ Sokol 1987 Successful pregnancy following steroid therapy and plasma exchange in a woman with anti-Ro (SS-A) antibodies. Case report Br J Obstet Gynaecol 94 369 371 1:STN:280:DyaL2s3hsVSqug%3D%3D 3495290 (Pubitemid 17053197)
15. RM Watson BL Braunstein AJ Watson MC Hochberg TT Provost 1986 Fetal wastage in women with anti-Ro(SSA) antibody J Rheumatol 13 90 94 1:STN:280:DyaL287pvF2rtg%3D%3D 3486290 (Pubitemid 16118730)
16. H Julkunen R Kaaja P Kurki T Palosuo C Friman 1995 Fetal outcome in women with primary Sjogren's syndrome. A retrospective case-control study Clin Exp Rheumatol 13 65 71 1:STN:280:DyaK2M3pt1Cntw%3D%3D 7774105
17. CP Mavragani UG Dafni AG Tzioufas HM Moutsopoulos 1998 Pregnancy outcome and anti-Ro/SSA in autoimmune diseases: a retrospective cohort study Br J Rheumatol 37 740 745 1:STN:280:DyaK1cznvVWmsw%3D%3D 9714349
18. HD Le Thi B Wechsler JC Piette O Bletry P Godeau 1994 Pregnancy and its outcome in systemic lupus erythematosus QJM 87 721 729
19. GK Bertsias JP Ioannidis J Boletis, et al. 2008 EULAR recommendations for the management of systemic lupus erytematosus. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics Ann Rheum Dis 67 195 205 1:STN:280:DC%2BD1c%2FisVOqsA%3D%3D 17504841 (Pubitemid 351183308)
20. A Brucato A Doria M Frassi, et al. 2002 Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study Lupus 11 716 721 1:STN:280:DC%2BD38jht1Gnug%3D%3D 12475001 (Pubitemid 35408076)
21. M Michaëlsson MA Engle 1972 Congenital complete heart block: an international study of the natural history Cardiovasc Clin 4 85 101 4273004
22. MK Siren H Julkunen R Kaaja 1998 The increasing incidence of isolated congenital heart block in Finland J Rheumatol 25 1862 1864 1:STN:280: DyaK1cvgt1eisA%3D%3D 9733476 (Pubitemid 28439289)
23. A Brucato A Jonzon D Friedman, et al. 2003 Proposal for a new definition of congenital complete atrioventricular block Lupus 12 427 435 1:STN:280:DC%2BD3szktVKnsA%3D%3D 12873043 (Pubitemid 36830115)
24. JP Buyon A Brucato DM Friedman 2008 What's in a name? Ann Rheum Dis 67 732 1:STN:280:DC%2BD1c3kslyqsw%3D%3D 18408119 (Pubitemid 351571950)
25. A Brucato C Grava M Bortolati, et al. 2009 Congenital heart block non associated with anti-Ro/La antibodies comparison with anti-Ro/La-positive cases J Rheumatol 36 1744 1748 19567621
26. M Reichlin A Brucato MB Frank, et al. 1994 Concentration of autoantibodies to native 60-kd Ro/SS-A and denatured 52-kd Ro/SS-A in eluates from the heart of a child who died with congenital complete heart block Arthritis Rheum 37 1698 1703 1:STN:280:DyaK2M%2FntFGnuw%3D%3D 7980679
27. A Brucato M Frassi F Franceschini, et al. 2001 Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women Arthritis Rheum 44 1832 1835 1:CAS:528:DC%2BD38XpvFI%3D 11508435 (Pubitemid 32758230)
28. W Cheng B Li J Kajstura, et al. 1995 Stretch-induced programmed myocyte cell death J Clin Invest 96 2247 2259 1:CAS:528:DyaK28XltF2isg%3D%3D 7593611
29. TN James 1994 Normal and abnormal consequences of apoptosis in the human heart: from postnatal morphogenesis to paroxysmal arrhythmias Circulation 90 556 573 1:STN:280:DyaK2c3pvVajsA%3D%3D 8026044 (Pubitemid 24203723)
30. ME Miranda CE Tseng W Rashbaum, et al. 1998 Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes J Immunol 161 5061 5069 1:CAS:528:DyaK1cXntVWms7w%3D 9794444 (Pubitemid 28492089)
31. ME Miranda-Carús AD Askanase RM Clancy, et al. 2000 Anti-SSA/Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of tumor necrosis factor a by macrophages J Immunol 165 5345 5351 11046070
32. RM Clancy AD Askanase RP Kapur, et al. 2002 Transdifferentiation of cardiac fibroblasts, a fetal factor in anti-SSA/Ro-SSB/La antibody-mediated congenital heart block J Immunol 169 2156 2163 1:CAS:528:DC%2BD38XmtFejt70%3D 12165545 (Pubitemid 34857683)
33. YS Ho E Esscher RH Anderson M Michaëlsson 1986 Anatomy of congenital complete heart block and relation to maternal anti-Ro antibodies Am J Cardiol 58 291 294 1:STN:280:DyaL283pt1Ohuw%3D%3D 3090867 (Pubitemid 16052720)
34. JB Carter LC Blieden JE Edwards 1974 Congenital heart block: anatomic correlations and review of the literature Arch Pathol 97 51 57 1:STN:280:DyaE2c%2Fkt1aqtg%3D%3D 4808444
35. GR Hogg 1957 Congenital acute lupus erythematosus associated with subendocardial fibroelastosis: report of a case Am J Clin Pathol 28 648 654 1:STN:280:DyaG1c%2FltFeksw%3D%3D 13508585
36. RM Clancy PJ Neufing P Zheng, et al. 2006 Impaired clearance of apoptotic cardiocytes linked to anti-SSA/Ro-SSB/La antibodies in pathogenesis of congenital heart block J Clin Invest 116 2413 2422 1:CAS:528: DC%2BD28Xps1SgsLk%3D 16906225 (Pubitemid 44330140)
37. MR Awad A El-Gamel P Hasleton DM Turner PJ Sinnott II Hutchinson 1998 Genotypic variation in the transforming growth factor beta 1 gene: association with transforming growth factor beta 1 production, fibrotic lung disease, and graft fibrosis after lung transplantation Transplantation 66 1014 1020 1:CAS:528:DyaK1cXnsFelurw%3D 9808485 (Pubitemid 28513380)
38. AJ Franko J Sharplin A Ghahary MH Barcellos-Hoff 1997 Immunohistochemical localization of transforming growth factor beta and tumour necrosis factor alpha in the lungs of fibrosis-prone and "non-fibrosing" mice during the latent period and early phase after irradiation Radiat Res 147 245 256 1:CAS:528:DyaK2sXps1aitg%3D%3D 9008217
39. SH Phan SL Kunkel 1992 Lung cytokine production in bleomycin-induced pulmonary fibrosis Exp Lung Res 18 29 43 1:CAS:528:DyaK38XksVGks7s%3D 1374023
40. Y Nakamura L Tate RF Ertl, et al. 1995 Bronchial epithelial cells regulate fibroblast proliferation Am J Physiol 269 L377 L387 1:CAS:528:DyaK2MXotlWqsrc%3D 7573472
41. A El-Gamel MR Awad PS Hasleton, et al. 1999 Transforming growth factor beta 1 genotype and lung allograft fibrosis J Heart Lung Transplant 18 517 523 1:STN:280:DyaK1MzitFaksA%3D%3D 10395349 (Pubitemid 29291657)
42. RM Clancy CB Backer X Yin RP Kapur Y Molad JP Buyon 2003 Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNFα and TGFb1 to the pathogenesis of autoimmune-associated congenital heart block J Immunol 171 3253 3261 1:CAS:528:DC%2BD3sXmvFGqu7Y%3D 12960355 (Pubitemid 37093552)
43. R Cimaz MO Borghi M Gerosa M Biggioggero E Raschi PL Meroni 2006 Transforming growth factor beta1 in the pathogenesis of autoimmune congenital complete heart block: lesson from twins and triplets discordant for the disease Arthritis Rheum 54 356 359 1:CAS:528:DC%2BD28XhsVensbc%3D 16385528 (Pubitemid 43122220)
44. VP Werth W Zhang K Dortzbach K Sullivan 2000 Association of a promoter polymorphism of tumor necrosis factor-alpha with subacute cutaneous lupus erythematosus and distinct photoregulation of transcription J Invest Dermatol 115 726 730 1:CAS:528:DC%2BD3cXnt1yltbw%3D 10998151
45. KE Sullivan C Wooten BJ Schmeckpeper D Goldman MA Petri 1997 A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans Arthritis Rheum 40 2207 2211 1:CAS:528:DyaK1cXltVClsg%3D%3D 9416858 (Pubitemid 28016417)
46. AG Wilson N de Vries F Pociot FS di Giovine LB van der Putte GW Duff 1993 An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles J Exp Med 177 557 560 1:CAS:528:DyaK3sXnvFWgtw%3D%3D 8426126 (Pubitemid 23117109)
47. RM Clancy CB Backer X Yin, et al. 2004 Genetic association of cutaneous neonatal lupus with HLA class II and tumor necrosis factor alpha: implications for pathogenesis Arthritis Rheum 50 2598 2603 1:CAS:528:DC%2BD2cXnsVKht7k%3D 15334474 (Pubitemid 39062721)
48. E Alexander JP Buyon TT Provost T Guarnieri 1992 Anti-Ro/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model: in vitro electrophysiologic and immunocytochemical studies Arthritis Rheum 35 176 189 1:STN:280:DyaK387jsVeqsw%3D%3D 1734907
49. S Garcia JHM Nascimento E Bonfa, et al. 1994 Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts J Clin Invest 93 718 724 1:CAS:528:DyaK2cXis1Orsr8%3D 8113406 (Pubitemid 24072814)
50. M Boutjdir L Chen ZH Zhang, et al. 1998 Serum and immunoglobulin G from the mother of a child with congenital heart block induce conduction abnormalities and inhibit L-type calcium channels in a rat heart model Pediatr Res 44 11 19 1:CAS:528:DyaK1cXksFSjt7k%3D 9667364 (Pubitemid 28303438)
51. JA Mazel N El Sherif J Buyon M Boutjdir 1999 Electrocardiographic abnormalities in a murine model injected with IgG from mothers of children with congenital heart block Circulation 99 1914 1918 1:STN:280:DyaK1M3hs1ertg%3D%3D 10199891 (Pubitemid 29181423)
52. GQ Xiao K Hu M Boutjdir 2001 Direct inhibition of expressed cardiac L- and t-type calcium channels by IgG from mothers whose children have congenital heart block Circulation 103 1599 1604 1:CAS:528:DC%2BD3MXivFClur8%3D 11257091 (Pubitemid 32226271)
53. S Salomonsson SE Sonesson L Ottosson, et al. 2005 Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block J Exp Med 201 11 17 1:CAS:528:DC%2BD2MXjvVeltw%3D%3D 15630133 (Pubitemid 40130078)
54. KG Schmidt HE Ulmer NH Silverman CS Kleinman JA Copel 1991 Perinatal outcome of fetal complete atrioventricular block: a multicenter experience J Am Coll Cardiol 17 1360 1366 1:STN:280:DyaK3M3gtFKlsw%3D%3D 2016455
55. V Fesslova G Vignati A Brucato, et al. 2009 The impact of treatment of the fetus by maternal therapy on the fetal and postnatal outcomes for fetuses diagnosed with isolated complete atrioventricular block Cardiol Young 19 282 290 19383179
56. G Vignati A Brucato MP Pisoni, et al. 1999 Clinical course of pre- and post-natal isolated congenital atrioventricular block diagnosed in utero G Ital Cardiol 29 1478 1487 1:STN:280:DC%2BD3c7ltFOhtQ%3D%3D 10687111 (Pubitemid 30026686)
57. LM Lopes GM Tavares AP Damiano, et al. 2008 Perinatal outcome of fetal atrioventricular block: one-hundred-sixteen cases from a single institution Circulation 118 1268 1275 18765396
58. M Eronen MK Siren H Ekblad T Tikanoja H Julkunen T Paavilainen 2000 Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn Pediatrics 106 86 91 1:STN:280: DC%2BD3czovFSisA%3D%3D 10878154 (Pubitemid 30436877)
59. JP Moak KS Barron TJ Hougen, et al. 2001 Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela J Am Coll Cardiol 37 238 242 1:STN:280:DC%2BD3M%2Fptlyqtw%3D%3D 11153745 (Pubitemid 32051745)
60. FE Udink ten Cate JM Breur MI Cohen, et al. 2001 Dilated cardiomyopathy in isolated congenital complete atrioventricular block: early and long-term risk in children J Am Coll Cardiol 37 1129 1134 1:STN:280:DC%2BD3M7mtlKrtg%3D%3D 11263619 (Pubitemid 32217617)
61. LE Nield ED Silverman JF Smallhorn, et al. 2002 Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block J Am Coll Cardiol 40 796 802 1:CAS:528:DC%2BD38XntVKjsrs%3D 12204513 (Pubitemid 34925629)
62. AD Askanase DM Friedman J Copel, et al. 2002 Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies Lupus 11 145 151 1:CAS:528:DC%2BD38XjsFGitr4%3D 11999879 (Pubitemid 34296929)
63. A Brucato R Cimaz L Catelli PL Meroni 2000 Anti-Ro associated sinus bradycardia in newborns Circulation 102 E88 E99 1:STN:280:DC%2BD3cvls1Kktg%3D%3D 10982556
64. R Cimaz M Stramba-Badiale A Brucato L Catelli P Panzeri PL Meroni 2000 QT interval prolongation in asymptomatic anti-SSA/Ro positive infants without congenital heart block Arthritis Rheum 43 1049 1053 1:STN:280: DC%2BD3c3nsFamuw%3D%3D 10817558 (Pubitemid 30368182)
65. PE Lazzerini M Acampa F Guideri, et al. 2004 Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases Arthritis Rheum 50 1248 1252 15077308 (Pubitemid 38480836)
66. N Costedoat-Chalumeau Z Amoura JM Lupoglazoff, et al. 2004 Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group Arthritis Rheum 50 3187 3194 15476223 (Pubitemid 39371995)
67. DM Friedman MY Kim JA Copel, et al. 2008 Utility of Cardiac monitoring in fetuses at risk for congenital heart block. the pr interval and dexamethasone evaluation (pride) prospective study Circulation 117 485 493 18195175
68. M Motta C Rodriguez-Perez A Tincani A Lojacono G Chirico 2007 Outcome of infants from mothers with anti-SSA/Ro antibodies J Perinatol 27 278 283 1:CAS:528:DC%2BD2sXksFSisrc%3D 17363909 (Pubitemid 46647904)
69. M Gerosa R Cimaz M Stramba-Badiale, et al. 2007 Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases-a multicentre prospective study Rheumatology 46 1285 1289 1:STN:280: DC%2BD2svisl2jug%3D%3D 17449486 (Pubitemid 47244502)
70. LA Lee WL Weston 1997 Cutaneous lupus erythematosus during the neonatal and childhood periods Lupus 6 132 138 1:STN:280:DyaK2s3hsFaqtA%3D%3D 9061661 (Pubitemid 27102040)
71. AR Neiman LA Lee WL Weston JP Buyon 2000 Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry J Pediatr 137 674 680 1:STN:280: DC%2BD3M%2FltVShug%3D%3D 11060534
72. R Watson JE Kang M May M Hudak T Kickler TT Provost 1988 Trombocytopenia in the neonatal lupus syndrome Arch Dermatol 124 560 563 1:STN:280: DyaL1c7ot1eisQ%3D%3D 3258497
73. S Kanagasegar R Cimaz BT Kurien A Brucato RH Scofield 2002 Neonatal lupus manifests as isolated neutropenia and mildly abnormal liver functions J Rheumatol 29 187 191 11824959 (Pubitemid 34041878)
74. RM Laxer EA Roberts KR Gross, et al. 1990 Liver disease in neonatal lupus erythematosus J Pediatr 116 238 242 1:STN:280:DyaK3c7jtlaiuw%3D%3D 2299493 (Pubitemid 20056778)
75. LA Lee 1993 Neonatal lupus erythematosus J Invest Dermatol 100 9S 13S 1:STN:280:DyaK3s7jvFKjsg%3D%3D 8423406 (Pubitemid 23035886)
76. R Cimaz DL Spence L Hornberger ED Silverman 2003 Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies J Pediatr 142 678 683 12838197 (Pubitemid 36737172)
77. G Ross L Sammaritano R Nass M Lockshin 2003 Effects of mothers' autoimmune disease during pregnancy on learning disabilities and hand preference in their children Arch Pediatr Adolesc Med 157 397 402 12695238 (Pubitemid 36443714)
78. CA Boros D Spence S Blaser ED Silverman 2007 Hydrocephalus and macrocephaly: new manifestations of neonatal lupus erythematosus Arthritis Rheum 57 261 266 17330304 (Pubitemid 47164088)
79. A Brucato M Gasparini G Vignati, et al. 1995 Isolated congenital heart block: longterm outcome of children and immunogenetic study J Rheumatol 22 541 543 1:STN:280:DyaK2Mzgt1elsA%3D%3D 7783077
80. V Martin LA Lee AD Askanase M Katholi JP Buyon 2002 Long-term followup of children with neonatal lupus and their unaffected siblings Arthritis Rheum 46 2377 2383 12355485
81. R Cimaz 2004 Any increased risk of autoimmune disease? Lupus 13 736 739 1:STN:280:DC%2BD2crhsVymug%3D%3D 15485114 (Pubitemid 39279794)
82. H Julkunen P Kurki R Kaaja, et al. 1993 Isolated congenital heart block. Long-term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La Arthritis Rheum 36 1588 1598 1:STN:280: DyaK2c%2FlvFWquw%3D%3D 8240435 (Pubitemid 23327758)
83. J Waltuck JP Buyon 1994 Autoantibody-associated congenital heart block: outcome in mothers and children Ann Intern Med 120 544 551 1:STN:280: DyaK2c7mtFCjug%3D%3D 8116991 (Pubitemid 24091594)
84. A Brucato F Franceschini M Gasparini, et al. 1995 Isolated congenital complete heart block: longterm outcome of mothers, maternal antibody specificity and immunogenetic background J Rheumatol 22 533 540 1:STN:280: DyaK2Mzgt1elsw%3D%3D 7783076
85. J Press Y Uziel RM Laxer L Luy RM Hamilton ED Silverman 1996 Long-term outcome of mothers of children with complete congenital heart block Am J Med 100 328 332 1:STN:280:DyaK283gt1ymsw%3D%3D 8629679 (Pubitemid 26111630)
86. TL Rivera PM Izmirly BK Birnbaum, et al. 2008 Disease progression in mothers of children enrolled in the Resaerch Registry for Neonatal Lupus Ann Rheum Dis 68 6 828 835 18625627
87. Gladman G, Silverman ED, Law Y et al (2002) Fetal echocardiographic screening of pregnancies of mothers with anti-Ro and/or anti-La antibodies. Am J Perinatol 19:73-80
88. AJ Rein D Mevorach Z Perles, et al. 2009 Early Diagnosis and Treatment of Atrioventricular Block in the Fetus Exposed to Maternal Anti-SSA/Ro-SSB/La Antibodies: a prospective, observational, fetal kinetocardiogram-based study Circulation 119 1867 1872 1:CAS:528:DC%2BD1MXktF2msbo%3D 19332471
89. P Gordon MA Khamashta E Rosenthal, et al. 2004 Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus J Rheumatol 31 2480 2487 1:CAS:528:DC%2BD2MXivFKqsA%3D%3D 15570655 (Pubitemid 39603101)
90. D Spence L Hornberger R Hamilton ED Silverman 2006 Increased risk of complete congenital heart block in infants born to women with hypothyroidism and anti-Ro and/or anti-La antibodies J Rheumatol 33 167 170 1:CAS:528: DC%2BD28Xps1aitQ%3D%3D 16292791 (Pubitemid 43054298)
91. AD Askanase I Iloh JP Buyon 2006 Hypothyroidism and antithyroglobulin and antithyroperoxidase antibodies in the pathogenesis of autoimmune associated congenital heart block J Rheumatol 33 2099 17014028
92. JP Buyon R Hiebert J Copel, et al. 1998 Autoimmune-associated congenital heart block: mortality, morbidity, and recurrence rates obtained from a national neonatal lupus registry J Am Coll Cardiol 31 1658 1666 1:STN:280: DyaK1c3ovVGgtQ%3D%3D 9626848 (Pubitemid 28273312)
93. H Julkunen M Eronen 2001 The rate of recurrence of isolated congenital heart block: a population-based study Arthritis Rheum 44 487 488 1:STN:280:DC%2BD3M7lvFSisA%3D%3D 11229483
94. JP Buyon RJ Winchester SG Slade, et al. 1993 Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies Arthritis Rheum 36 1263 1273 1:STN:280:DyaK2c%2FjtVWgtQ%3D%3D 8216420 (Pubitemid 23303117)
95. D Rosenthal M Druzin C Chin A Dubin 1998 A new therapeutic approach to the fetus with congenital complete heart block: prevemptive, targeted therapy with dexamethasone Obstet Gynecol 92 689 691 1:STN:280:DyaK1cvjsFKqtw%3D%3D 9764666 (Pubitemid 28440795)
96. K Shinohara S Miyagawa T Fujita T Aono K Kidoguchi 1999 Neonatal lupus erythematosus: results of maternal corticosteroid therapy Obstet Gynecol 93 952 957 1:STN:280:DyaK1M3ovFSjtQ%3D%3D 10362161 (Pubitemid 29247102)
97. S Sonesson S Salomonsson LA Jacobsson K Bremme M Wahren-Herlenius 2004 Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies Arthritis Rheum 50 1253 1261 1:CAS:528:DC%2BD2cXjslGqs7c%3D 15077309 (Pubitemid 38480837)
98. S Saleeb J Copel D Friedman JP Buyon 1999 Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus Arthritis Rheum 42 2335 2345 1:CAS:528:DyaK1MXnvVShsLk%3D 10555029 (Pubitemid 30333414)
99. E Theander A Brucato S Gudmundsson S Salomonsson M Wahren-Herlenius R Manthorpe 2001 Primary Sjogren's syndrome-treatment of fetal incomplete atrioventricular block with dexamethasone J Rheumatol 28 373 376 1:STN:280:DC%2BD3MzjvVeqsw%3D%3D 11246681 (Pubitemid 32165152)
100. DM Friedman MY Kim JA Copel C Llanos C Davis JP Buyon 2009 Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study Am J Cardiol 103 1102 1106 19361597
101. ET Jaeggi JC Fouron ED Silverman G Ryan J Smallhorn JK Hornberger 2004 Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease Circulation 110 1542 1548 15353508 (Pubitemid 39297974)
102. JM Breur GH Visser AA Kruize P Stoutenbeek EJ Meijboom 2004 Treatment of fetal heart block with maternal steroid therapy: case report and review of the literature Ultrasound Obstet Gynecol 24 467 472 1:STN:280:DC%2BD2cvjsl2gsg%3D%3D 15343606 (Pubitemid 39179486)
103. R Kaaja H Julkunen 2003 Prevention of recurrence of congenital heart block with intravenous immunoglobulin and corticosteroid therapy: comment on the editorial by Buyon et al. Arthritis Rheum 48 280 281 12528144
104. HB Tran D Cavill JP Buyon TP Gordon 2004 Intravenous immunoglobulin and placental transport of anti-Ro/La antibodies: comment on the letter by Kaaja and Julkunen Arthritis Rheum 50 337 338 14730639 (Pubitemid 38084324)
105. S Matsubara Y Morimatsu H Shiraishi, et al. 2008 Fetus with heart failure due to congenital atrioventricular heart block treated by maternally administered ritodrine Arch Gynecol Obstet 278 85 88 1:CAS:528: DC%2BD1cXmtlygu78%3D 18066569
106. AM Groves LD Allan E Rosenthal 1995 Therapeutic trial of sympathomimetics in three cases of complete heart block in the fetus Circulation 92 3394 3396 1:CAS:528:DyaK28Xlt1eiug%3D%3D 8521558
107. NP French R Hagan SF Evans M Godfrey JP Newnham 1999 Repeated antenatal corticosteroids: size at birth and subsequent development Am J Obstet Gynecol 180 114 121 1:CAS:528:DyaK1MXht1ajtrc%3D 9914589 (Pubitemid 29088400)
108. S Abbasi D Hirsch J Davis, et al. 2000 Effect of single versus multiple courses of antenatal corticosteroids on maternal and neonatal outcome Am J Obstet Gynecol 182 1243 1249 1:CAS:528:DC%2BD3cXktFClsb4%3D 10819866 (Pubitemid 30353319)
109. A Spinillo F Viazzo R Colleoni A Chiara RA Cerbo E Fazzi 2004 Two-year infant neurodevelopmental outcome after single or multiple antenatal courses of corticosteroids to prevent complications of prematurity Am J Obstet Gynecol 191 217 224 1:CAS:528:DC%2BD2cXmsVeqsLc%3D 15295369 (Pubitemid 39077979)
110. AH Jobe RF Soll 2004 Choice and dose of corticosteroid for antenatal treatments Am J Obstet Gynecol 190 878 881 1:CAS:528:DC%2BD2cXkvVGlsLo%3D 15118606 (Pubitemid 38561501)
111. R Urban A Lemancewicz J Przepiesc J Urban M Kretowska 2005 Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal Doppler flow velocity waveforms Eur J Obstet Gynecol Reprod Biol 120 170 174 1:CAS:528:DC%2BD2MXltVentb0%3D 15925046 (Pubitemid 40745320)
112. Crowley P (1999) Prophylactic corticosteroids for preterm delivery. In: The Cochrane library. Issue 4. Oxford: Update software.
113. A Brucato MG Astori R Cimaz, et al. 2006 Normal neuropsychological development of children with congenital complete heart block exposed or not in utero to high-dose dexamethasone Ann Rheum Dis 65 1422 1426 1:CAS:528: DC%2BD28Xht1OjtL%2FJ 16504990 (Pubitemid 44629116)